Depression-like phenotype following chronic CB1 receptor antagonism

Beyer, Chad E., Dwyer, Jason M., Piesla, Michael J., Platt, Brian J., Shen, Ru, Rahman, Zia, Chan, Karen, Manners, Melissa T., Samad, Tarek A., Kennedy, Jeffrey D., Bingham, Brendan, Whiteside, Garth T.·2010·Neurobiology of Disease
DOI 10.1016/j.nbd.2010.03.020

Cited by (159)

Items 101–159 of 159

  1. The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety
    Eric Murillo‐Rodríguez, Jocelyne Alcaraz-Silva, Daniel Feingold, Gerardo Viana-Torre, Henning Budde, Claudio Imperatori, Sergio Eduardo de Carvalho Machado · 2022 · CNS & Neurological Disorders - Drug Targets
  2. - Role of the Endocannabinoid System in the Neurobiology of Suicide
    Yogesh Dwivedi · 2012 · CRC Press eBooks
  3. Effects of pro‐depressant and immunomodulatory drugs on biases in decision‐making in the rat judgement bias task
    Claire A. Hales, Julia M. Bartlett, Roberto Arban, Bastian Hengerer, Emma S. J. Robinson · 2021 · European Journal of Neuroscience
  4. Effects of the antipsychotic paliperidone on stress-induced changes in the endocannabinoid system in rat prefrontal cortex
    Karina S. MacDowell, Aline Sayd, Borja García‐Bueno, Javier R. Caso, José L. M. Madrigal, Juan Carlos Leza · 2016 · The World Journal of Biological Psychiatry
  5. The Endocannabinoid System in Prefrontal Synaptopathies
    Andrew F. Scheyer, Henry G. S. Martin, Olivier J. Manzoni · 2017 · Springer eBooks
  6. Brain region specific regulation of anandamide (down) and sphingosine-1-phosphate (up) in association with anxiety (AEA) and resilience (S1P) in a mouse model of chronic unpredictable mild stress
    Caroline Fischer, Dominique Thomas, Robert Gurke, Irmgard Tegeder · 2024 · Pflügers Archiv - European Journal of Physiology
  7. Modern approaches to the development of synthetic cannabinoid receptor probes
    Savanah L. Saldaña-Shumaker, Alexander J. Grenning, Christopher W. Cunningham · 2021 · Pharmacology Biochemistry and Behavior
  8. RTICBM-74 Is a Brain-Penetrant Cannabinoid Receptor Subtype 1 Allosteric Modulator that Reduces Alcohol Intake in Rats
    Dennis F. Lovelock, Thuy Nguyen, Kalynn J. Van Voorhies, Yanan Zhang, Joyce Besheer · 2021 · Journal of Pharmacology and Experimental Therapeutics
  9. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case–control association study
    Chenghao Yang, Ilja Maria Nolte, Yanyan Ma, Xuguang An, Fokko J. Bosker, Jie Li · 2021 · Molecular Genetics & Genomic Medicine
  10. Cannabinoid-mediated diversity of antinociceptive efficacy of parecoxib in Wistar and Sprague Dawley rats in the chronic constriction injury model of neuropathic pain
    Axel Becker, Gerd Geißlinger, Radovan Murín, Gisela Grecksch, Volker Höllt, Andreas Zimmer, Helmut Schröder · 2013 · Naunyn-Schmiedeberg s Archives of Pharmacology
  11. Animal Models of Risk Factors for Suicidal Ideation and Behaviour
    Sarah A. Stuart, Paul Butler, Emma S. J. Robinson · 2014 · Springer eBooks
  12. The role of cannabinoid-mediated signaling pathways and mechanisms in brain disorders
    Shunfeng Liu, Zegang Ma · 2025 · Cellular Signalling
  13. Depression Onset in Long-term Adolescent Cannabinoid Use: A Neurobiological Review
    Shawn Y Forrester, Nusrat Jahan · 2020 · Cureus
  14. CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects
    Pedro Henrique Gobira, Jacob LaMar, J. S. Marques, Ariandra Guerini Sartim, Kennia Moura Silveira, Luana Oliveira dos Santos, Gregers Wegener, Francisco Silveira Guimarães, Ken Mackie, Hui‐Chen Lu et al. · 2022 · Cannabis and Cannabinoid Research
  15. Dopamine, activation of ingestion and evaluation of response efficacy: a focus on the within-session time-course of licking burst number
    Paolo S. D’Aquila · 2024 · Psychopharmacology
  16. CB1 receptor signaling: Linking neuroplasticity, neuronal types, and mental health outcomes
    Qianqian Gao, Muhammad Asim · 2025 · Neurochemistry International
  17. Disease‐associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue‐specific activity of the cannabinoid‐1 receptor gene promoter; implications for cannabinoid pharmacogenetics
    Elizabeth A. Hay, Philip Cowie, Andrew R. McEwan, Ruth A. Ross, Roger G. Pertwee, Alasdair MacKenzie · 2019 · Human Mutation
  18. Pharmacological comparison of traditional and non-traditional cannabinoid receptor 1 blockers in rodent models in vivo
    Balázs Varga, Ferenc Kassai, György Szabó, Péter Kovács, János Fischer, István Gyertyán · 2017 · Pharmacology Biochemistry and Behavior
  19. Optimization of the Heterologous Expression of the Cannabinoid Type-1 (CB1) Receptor
    Viktória Bea Horváth, Eszter Soltész‐Katona, Éva Wisniewski, Anikó Rajki, Eszter Halász, Balázs Enyedi, László Hunyady, András Dávid Tóth, Gergő Szanda · 2021 · Frontiers in Endocrinology
  20. Computational Prediction and Biochemical Analyses of New Inverse Agonists for the CB1 Receptor
    Caitlin E. Scott, Kwang H. Ahn, Steven T. Graf, William A. Goddard, Debra A. Kendall, Ravinder Abrol · 2015 · Journal of Chemical Information and Modeling
  21. Endocannabinoid system in trauma and psychosis: distant guardian of mental stability
    Tomasz Bielawski, Lucas Albrechet‐Souza, Dorota Frydecka · 2021 · Reviews in the Neurosciences
  22. Role of the Endocannabinoid System in the Neurobiology of Suicide
    K Vinod · 2012 · Frontiers in neuroscience
  23. Considerations on nonclinical approaches to modeling risk factors of suicidal ideation and behavior
    Susan M.G. Goody, Kerena Cannon, M. Liu, Mary Jeanne Kallman, Jean-Pierre Martinolle, Ludmilla Mazelin-Winum, Alessandra Giarola, Paul A. Ardayfio, John A. Moyer, Greet Teuns et al. · 2017 · Regulatory Toxicology and Pharmacology
  24. Neural Receptors Associated with Depression: A Systematic Review of the Past 10 Years
    Alice Barros Câmara, Igor Augusto Brandão · 2020 · CNS & Neurological Disorders - Drug Targets
  25. Combined administration of intracerebroventricular CB1 agonist ACEA and systemic TRPV1 agonist capsaicin induces synergistic antidepressant-like effects in rats
    Daniela A. Avalos-Moreno, Sergio Guillermo Cuevas-Carbonell, Metzli E. Ramírez-Vargas, Luis Castro‐Sánchez, Adolfo Virgen‐Ortiz, Enrique Alejandro Sánchez-Pastor, José Luis Góngora-Alfaro, Ricardo A. Navarro‐Polanco, Eloy Gerardo Moreno-Galindo, Javier Alamilla · 2026 · Behavioural Brain Research
  26. The chronic pharmacological antagonism of the CB1 receptor is not involved in the behavioral effects of antidepressants administered in mice submitted to chronic unpredictable stress
    Melissa A. Ribeiro, Rafael Pazinatto Aguiar, Franciele Franco Scarante, Eduardo Junji Fusse, Rúbia Maria Weffort de Oliveira, Francisco Silveira Guimarães, Alline Cristina Campos · 2023 · Behavioural Brain Research
  27. Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine densities in brain regions important to zebra finch vocal learning and production in an antidepressant-sensitive manner
    Tessa L. Holland, Ken Soderstrom · 2017 · Brain Research
  28. Microstructure analysis of the effects of the cannabinoid agents HU-210 and rimonabant in rats licking for sucrose
    Paolo S. D’Aquila · 2020 · European Journal of Pharmacology
  29. Genetic, epigenetic and pharmacological influences modulating tissue specific regulation of the cannabinoid receptor-1 gene (CB 1 ); implications for cannabinoid pharmacogenetics
    Elizabeth A. Hay, Philip Cowie, Andrew R. McEwan, Dana Wilson, Ruth A. Ross, Perry Barrett, Roger G. Pertwee, Alasdair MacKenzie · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Synthesis and Biological Evaluation of Pyrrolo[2,3-d]pyrimidine Derivatives as Novel Apoptotic Agents for Human Lung Cancer Cells
    K. M. H. HILMY, Fawzya N. M. Kishk, Esmat B. A. Shahen, Mohamed A. Hawata · 2023 · Russian Journal of Organic Chemistry
  31. Endocannabinoid-mediated regulation of depression in the ovBNST
    Riming Zhu, Jie Li, Xia Zhang, Bin Zhang · 2025 · Frontiers in Neuroscience
  32. Cannabinoid treatment impacts adaptive behavior in autism patients and caregivers’ mental health: A prospective real-life cohort study
    Kelly Álvares Guimarães, Letícia Perígolo Jorge, Ana Luiza de Oliveira Resende, Estácio Amaro da Silva, Arthur Kümmer, Wilson A. Silva, Guilherme Nogueira Mendes de Oliveira · 2025 · Progress in brain research
  33. Endocannabinoids, Stress, and Negative Affect
    Anthony L. Berger, Angela M. Henricks, Matthew N. Hill, Ryan J. McLaughlin · 2017 · Springer eBooks
  34. Au delà des antidépresseurs sérotoninergiques? Nouvelles stratégies pharmacologiques
    , · 2012 · Schweizer Archiv für Neurologie und Psychiatrie
  35. Have the Genetics of Cannabis Involvement Gone to Pot?
    Arpana Agrawal A, Michael T. Lynskey · 2014 · Nebraska Symposium on Motivation/The Nebraska symposium on motivation
  36. Endocannabinoid Metabolism in Posttraumatic Stress Disorder: Results From a Neuroimaging Study With the Novel Fatty Acid Amide Hydrolase Probe, [C-11] Curb
    Erin V. Gaudette, Sarah E. Watling, Jerry J. Warsh, Tina McCluskey, Junchao Tong, Sylvain Houle, Pablo Rusjan, Shawn G. Rhind, Richard Paul Bazinet, Rachel Fynvola Tyndale et al. · 2020 · Biological Psychiatry
  37. Adolescent CB1 receptor expression at the BLA and CA1 and acute AM251 effects on sociability and emotional memory are sex-specific, and not modulated by heterotypic stress exposure
    Emmanuelle Person, Hélène Plamondon · 2025 · Behavioural Brain Research
  38. Anhedonia in Mouse Models of Methamphetamine-Induced Drug Seeking Behavior
    Junichi Kitanaka, Nobue Kitanaka, Frank Scott Hall, George R. Uhl, Motohiko Takemura · 2014 · Springer eBooks
  39. UNIVERSIDADE FEDERAL DE SANTA CATARINA CENTRO DE CIÊNCIAS BIOLÓGICAS DEPARTAMENTO DE FARMACOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM FARMACOLOGIA MODULAÇÃO DO COMPORTAMENTO DE RATOS SUBMETIDOS AO TESTE DO NADO FORÇADO PELO RECEPTOR VANILÓIDE DE POTENCIAL TRANSITÓRIO TIPO 1 DO HIPOCAMPO
    Ana Carolina Vanvossen · 2012
  40. Nicotine Reward and Abstinence: Role of the CB1 Receptors
    Salma Tannous, Stéphanie Caillé · 2019 · Elsevier eBooks
  41. Characterizing chronic non-suicidal self-injury and other forms of repetitive and escalating suicide behaviour as endocannabinoid-mediated pain and reward disorders
    Hye Ji J. Kim, David A. Petrishen, Robert B. Laprairie, Evyn M. Peters · 2022 · Personalized Medicine in Psychiatry
  42. Depression
    Kylie O’Brien, Philip Blair · 2021 · Springer eBooks
  43. Discriminative stimulus properties of 3-substituent rimonabant analogs
    D. Matthew Walentiny · 2011 · VCU Scholars Compass (Virginia Commonwealth University)
  44. Rimonabant: a CB1 receptor antagonist as a direct interactional partner for μ- and δ-opioid receptor
    Ferenc Zádor · 2014
  45. POSSIBLE EFFECTS OF THE ENDOCANNABINOID SYSTEM ON THE PATHOPHYSIOLOGY OF DEPRESSION: MEDICAL TREATMENT APPROACHES BASED ON THIS SYSTEM
    Ravza Nazlı Müyesseroğlu, Oğuzhan Yıldız · 2023 · TURKISH MEDICAL STUDENT JOURNAL
  46. Mood, Motivation, and Mental Health
    Jean-Paul Henri Dedam, Matthew Fogel, Elizabeth Fogel · 2025 · Springer eBooks
  47. Associations between cannabis use frequency and suicidal thoughts and behaviors: A clinical longitudinal sibling study
    Elisa F. Stern, Jarrod M. Ellingson, Jonathan D. Schaefer, Jesse D. Hinckley, Michael C. Stallings, Robin P. Corley, Christian Jean Hopfer, Tamara L. Wall, Soo Hyun Rhee · 2025 · Addictive Behaviors Reports
  48. Neurensin-2 is a negative regulator of CB1 receptor
    Yumna Abu Ghanem, Liora Dorfman-Yahad, Hadas Catane Hovav, Laila Agbariya, Adi Cohen, Hila Yehuda, Gali Umschweif · 2025 · Biochemical Pharmacology
  49. Modulation of Serotonin Firing Activity Through CB1 Agonists and FAAH Inhibitors
    Gabriella Gobbi · 2013 · Springer eBooks
  50. Peripheral CB1R inhibition modulates food intake and metabolic efficiency in obesity independently of the gut-brain vagal axis
    Oriane Onimus, Camille de Almeida, Benoit Bertrand, Julien Castel, Nejmeh Mashhour, Anthony Ansoult, Serge H. Luquet, Giuseppe Gangarossa · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Impact of CBG deficiency on emotional and cognitive processes
    Gabriela Ferreira de Medeiros · 2016 · theses.fr (ABES)
  52. Déficits synaptiques et comportementaux des voies méso-cortico-limbiques induits par le cannabis ou un déséquilibre alimentaire en acides gras polyinsaturés
    Anissa Bara · 2017 · theses.fr (ABES)
  53. Evaluating the cannabinoid CB1 receptor as a therapeutic target in a Shank3 mouse model of autism and Phelan-McDermid syndrome
    Flavio Tomasi · 2023 · theses.fr (ABES)
  54. Cellular and Behavioral Interactions of Cannabinoid and Opioid Systems in Pain, Mood, Reward, and Addiction
    Aida Mohammadkhani, Colleen S. Peterson, Stephanie L. Borgland · 2026 · Springer eBooks
  55. Communication in the Depressed Brain
    Franklin Sunzeri · 2026 · Springer eBooks
  56. Inhibition of peripheral CB 1 receptors modulates food intake and metabolic efficiency in obesity independently of the gut–brain vagal axis
    Oriane Onimus, Camille de Almeida, Benoit Bertrand, Julien Castel, Nejmeh Mashhour, Anthony Ansoult, Serge H. Luquet, Giuseppe Gangarossa · 2026 · British Journal of Pharmacology
  57. Muscone Exerts Rapid Antidepressant Effects Through Modulating Glutamatergic Neural Transmission in the Anterior Cingulate Cortex Against Peripheral Inflammation-induced Depression
    Xiaoyun Qiu, Xiaojie Zhang, Yuanzhi Yang, Minjuan Sun, Xiaoli Da, Jiaying Liu, Rui Wang, Jingjia Liang, Xuhong Jiang, Gang Tian et al. · 2026 · Neuroscience Bulletin
  58. Depression
    Kylie O’Brien, Philip Blair · 2026 · Springer eBooks
  59. CARDIOPROTECTIVE EFFECT OF THE CB1 RECEPTOR LIGAND HEMOPRESSIN ON DOXORUBICIN-INDUCED CARDIOTOXICITY IN RATS: A SCINTIGRAPHIC, ELECTROCARDIOGRAPHIC, AND BIOCHEMICAL STUDY
    Reyhan Köroğlu, Hatice Aygün · 2026 · Kocatepe Tıp Dergisi